FDC Stock Reaches 52-Week High After 'Hold' Rating by MarketsMOJO

FDC, a midcap pharmaceutical company, has recently seen a surge in its stock price, reaching a 52-week high of Rs.600 on September 10th, 2024. This comes after the company's stock call was given a 'Hold' rating by MarketsMOJO.

The stock has shown a strong performance today, outperforming the sector by 3.79%. It touched an intraday high of Rs.600, showing a 5.26% increase. FDC is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock price.

In the past year, FDC has shown a remarkable performance with a 50.17% increase, outpacing the Sensex's performance of 22.96%. This growth can be attributed to the company's strong presence in the pharmaceutical industry and its consistent efforts towards innovation and expansion.

FDC, with its focus on research and development, has a diverse portfolio of products catering to various therapeutic segments. The company has also been expanding its global presence through strategic partnerships and acquisitions.

With its strong financials and promising growth prospects, FDC continues to be a top player in the pharmaceutical industry. Investors can consider holding onto their FDC stocks as the company continues to show promising growth in the future.